ERcast: Clinical Perspectives Podcast Preview

Affordable Meds & Toxic Kids

Affordable Meds & Toxic Kids

  • Aug 18, 2026
  • 1 Chapter
  • 51 min

Medication cost is one of the most common and overlooked barriers to successful ED discharge. In this episode, Geoff sits down with an emergency medicine pharmacist, Sarah Divello, to discuss practical prescribing strategies that can improve medication affordability and adherence without compromising patient care. Packed with real-world pearls and bedside strategies, this episode will help you make prescribing decisions that increase the likelihood your patients actually leave the pharmacy with the medications they need.  Then,  Brett discusses high-risk pediatric ingestions with Clinical Pharmacist Jess Pescatore.   Toddlers and young children are naturally curious and often explore the world by putting things in their mouths. This behavior contributes to the high frequency of pediatric ingestions, which can be highly dangerous and even lethal from small exposures, often as little as one pill or teaspoon.

Chapters

Affordable Meds & Toxic Kids

Medication affordability is a major determinant of whether ED discharge plans succeed. Small prescribing choices like formulation, treatment duration, and pharmacist substitution can meaningfully change adherence. In toddlers, poisonings are usually exploratory and benign, but a short list of exposures can be life-threatening after a single pill or small sip. Lower-Cost ED Prescribing Pearls Formulation cost traps: Immediate-release tablets and capsules are usually far cheaper than liquids, ODTs, or extended-release products, and that single switch often matters more for adherence than the drug choice itself. Topicals and combo products: Creams or ointments are usually less expensive than foams, gels, or lotions, and combo products like doxylamine-pyridoxine often cost more than buying the ingredients separately. Practical OTC substitutions: OTC 4% lidocaine patches perform similarly to prescription 5% patches for many patients, and explicit dosing instructions can make ibuprofen, naproxen, or bowel regimens prescription-free. Antibiotic cost discipline: Older narrow-spectrum agents like cephalexin, amoxicillin, doxycycline, and TMP-SMX remain inexpensive workhorses, and many common infections only need 5 to 7 days of therapy. Pharmacist substitution language: A simple note allowing insurance-preferred equivalent formulations can prevent callbacks and treatment delays, especially with doxycycline forms, albuterol inhalers, and tablet-versus-capsule coverage. We get into the wording nuances in the episode. Hidden savings resources: Starter-pack coupons for apixaban or rivaroxaban can erase the first month cost, and 340B outpatient pharmacies may beat retail cash prices even when patients check GoodRx. Pediatric One-Pill-Kills Why children decompensate fast: Young children reach toxic doses quickly because of low body weight, limited glycogen stores, and poor cardiopulmonary reserve, so a well-appearing toddler can crash within hours. Scene-based ingestion history: Unwitnessed pediatric ingestions demand detective work: inventory the home, inspect for empty containers or pill fragments, and confirm whether the product was immediate- or extended-release. Early poison center partnership: Poison Control should be called early because observation, triage, and disposition often hinge on the exact product rather than the child's initial appearance. We walk through that framing in the chapter. High-risk prescription exposures: Buprenorphine, methadone, clonidine, guanfacine, propranolol, calcium channel blockers, sulfonylureas, and benzonatate can all cause severe toxicity after very small pediatric exposures. Named toxic red flags: Propranolol can produce sodium-channel blockade with QRS widening, methadone adds QT prolongation risk, and sulfonylureas are notorious for profound delayed hypoglycemia. Dangerous household products: Camphor can trigger rapid seizures, oil of wintergreen is an extremely concentrated salicylate source, and only a few milliliters of methanol or ethylene glycol may require antidotal therapy.

Faculty

  • Anne Steckowych, APRN

    Emergency medicine is in Anne’s blood; her father has been an Emergency Medicine physician for the last 30 years. After earning her nursing degree from the University of New Hampshire (UNH) in 2018, Anne worked as an EMT at her local fire department, gaining practical experience that prepared her for five years as a nurse in the emergency department. She eventually returned to UNH to become an NP and has spent the last 8 years in the same ED, building relationships with a clinical team dedicated to providing the best possible patient care. Outside of the hospital, she’s usually skiing, hiking, or running in the New Hampshire hills. ERcast is her first podcast, and she’s thrilled to be part of the Hippo team.

  • Brett Murray, MD

    Dr. Murray is an Emergency Medicine physician practicing at a busy community trauma center. After attending Boston University School of Medicine, he completed his residency training at Brown University / Rhode Island Hospital, where he also served as Chief Resident from 2020 – 2021. His clinical interests center on medical education, performance science, and Emergency Medical Services.

  • Geoffrey Comp, DO, FACEP

    Dr. Comp is an Associate Program Director for the Creighton University / Valleywise Health Emergency Medicine Residency Program in Phoenix. A clinician-educator at heart, Geoff spends his time mentoring the next generation of Emergency Medicine residents and advocating for better ways to teach and learn medicine. His professional world revolves around wilderness medicine, clinician wellness, and finding innovative ways to bridge the gap between theory and the bedside. When he isn’t in the ED or the classroom, you’ll likely find him combining his love for medicine with his passion for the outdoors, always looking for a new trail to explore or a new way to collaborate with fellow clinicians.

  • Jess Rivera Pescatore, PharmD

    Dr. Rivera earned her PharmD from the University of Florida. She completed a pharmacy practice residency at Lakeland Regional Health in Lakeland, Florida in 2011 and went on to complete a Clinical Toxicology/Emergency Medicine Fellowship with the Florida Poison Information Center at UF Health Jacksonville in Jacksonville, Florida. For the past 6 years, Dr. Rivera has practiced as a Clinical Pharmacist in Emergency Medicine at UAB Hospital in Birmingham, Alabama where she is an Associate Professor with the Department of Emergency Medicine. She is board-certified as a Diplomate of the American Board of Applied Toxicology and serves her institution’s Office for Medical Toxicology and the Alabama Poison Information Center as a Clinical Toxicologist

  • Sarah DiVello, PharmD